Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Experts Give Hualan Second Thumbs Up To Make H1N1 Flu Vaccine

This article was originally published in PharmAsia News

Executive Summary

China's Hualan Biological Engineering has been recommended by a panel of experts to be cleared for producing a single-shot H1N1 flu vaccine. The State FDA is to decide on the recommendation later in the week and whether to give Hualan a license to produce the drug. One day earlier, the same panel recommended Sinovac Biotech to be cleared to launch a vaccine intended for people between the age of 3 years old and 60 years old. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072794

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel